LifeMine Therapeutics (Switzerland) GmbH

Pharmaceuticals · Basel, Basel-Stadt

LifeMine Therapeutics (Switzerland) GmbH is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2022 (UID CHE-135.554.050). It is a subsidiary of LifeMine Therapeutics.

Legal nameLifeMine Therapeutics (Switzerland) GmbH
AddressAeschenplatz, Basel
UID / VATCHE-135.554.050
Legal form · StatusGmbH · Active · 2022
Parent companyLifeMine Therapeutics

Board members & signatories

  • Karen Guarco — Geschäftsführer
  • WeiQing Zhou — Geschäftsführer
  • LMTX Holdings Ltd. (Company No. 15885292) — Gesellschafter

Registered purpose

Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen Produkten und Technologien. Die Gesellschaft kann im In- und Ausland Tochtergesellschaften und Zweigniederlassungen errichten und sich im In- und Ausland an anderen Unternehmen beteiligen. Die Gesellschaft kann Grundstücke erwerben, halten und veräussern. Di…

🔒 Website🔒 Employees🔒 Revenue estimate

Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026

What LifeMine Therapeutics (Switzerland) does

OFFERING

LifeMine Therapeutics focuses on drug discovery and development, particularly through its lead clinical-stage program, LIFE-001, which is a precision-engineered calcineurin inhibitor aimed at treating multiple immune-mediated diseases and organ transplant rejection. The company employs a Top-Down Drug Discovery approach, leveraging insights from fungi to create next-generation precision medicines.

Unlock the full analysis →

Similar companies

Find every pharmaceuticals company in Switzerland

Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.

family-owned pharmaceuticals companies with 50+ employees…Search →

Full profiles from CHF 49/month · Cancel anytime